Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease
Nooshin Ghodsian, Erik Abner, Connor A. Emdin, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 11, pp. 100437-100437
Open Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study
Shuai Yuan, Jie Chen, Xue Li, et al.
European Journal of Epidemiology (2022) Vol. 37, Iss. 7, pp. 723-733
Open Access | Times Cited: 131
Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease
Ziang Li, Bin Zhang, Qing‐Rong Liu, et al.
EBioMedicine (2023) Vol. 90, pp. 104543-104543
Open Access | Times Cited: 83
NAFLD and NASH: etiology, targets and emerging therapies
Shulin Wei, Li Wang, Paul C. Evans, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 3, pp. 103910-103910
Closed Access | Times Cited: 59
Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study
Hexiang Peng, Siyue Wang, Mengying Wang, et al.
Metabolism (2022) Vol. 133, pp. 155220-155220
Closed Access | Times Cited: 58
Mendelian Randomization Analysis Reveals No Causal Relationship Between Nonalcoholic Fatty Liver Disease and Severe COVID-19
Jiuling Li, Aowen Tian, Haoxue Zhu, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 20, Iss. 7, pp. 1553-1560.e78
Open Access | Times Cited: 54
Whole-genome sequencing of half-a-million UK Biobank participants
Shuwei Li, Keren Carss, Bjarni V. Halldórsson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 40
Drug-target Mendelian randomization analysis supports lowering plasma ANGPTL3, ANGPTL4, and APOC3 levels as strategies for reducing cardiovascular disease risk
Fredrik Landfors, Peter Henneman, Elin Chorell, et al.
European Heart Journal Open (2024) Vol. 4, Iss. 3
Open Access | Times Cited: 10
Reductive stress: The key pathway in metabolic disorders induced by overnutrition
Shiyi Zhang, Na Wang, Zhichao Gao, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Body Fat Distribution and Ectopic Fat Accumulation as Mediator of Diabetogenic Action of Lipid-Modifying Drugs
Yuanlong Hu, Xinhai Cui, Mengkai Lu, et al.
Mayo Clinic Proceedings (2025)
Closed Access | Times Cited: 1
Human genetics of metabolic dysfunction–associated steatotic liver disease: from variants to cause to precision treatment
Vincent Chen, Annapurna Kuppa, Antonino Oliveri, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 7
Open Access | Times Cited: 1
Assessing the causal relationships between human blood metabolites and the risk of NAFLD: A comprehensive mendelian randomization study
Ziwei Guo, Tingyu Zhang, Zhangjun Yun, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 18
Impact of loss-of-function in angiopoietin-like 4 on the human phenome
Éloi Gagnon, Jérôme Bourgault, Émilie Gobeil, et al.
Atherosclerosis (2024) Vol. 393, pp. 117558-117558
Open Access | Times Cited: 8
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids
Kavitha Sasidharan, Andrea Caddeo, Oveis Jamialahmadi, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 1, pp. 101352-101352
Open Access | Times Cited: 7
Breaking down causes, consequences, and mediating effects of telomere length variation on human health
Samuel Moix, Marie C. Sadler, Zoltán Kutalik, et al.
Genome biology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 7
Homocysteine, folate, and nonalcoholic fatty liver disease: a systematic review with meta-analysis and Mendelian randomization investigation
Shuai Yuan, Jie Chen, Lintao Dan, et al.
American Journal of Clinical Nutrition (2022) Vol. 116, Iss. 6, pp. 1595-1609
Open Access | Times Cited: 28
Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease
Émilie Gobeil, Ina Maltais‐Payette, Nele Taba, et al.
Metabolites (2022) Vol. 12, Iss. 5, pp. 440-440
Open Access | Times Cited: 26
Time to transition from a negative nomenclature describing what NAFLD is not, to a novel, pathophysiology-based, umbrella classification of fatty liver disease (FLD)
Laura Valenzuela‐Vallejo, Christos S. Mantzoros
Metabolism (2022) Vol. 134, pp. 155246-155246
Closed Access | Times Cited: 26
Dissecting causal relationships between nonalcoholic fatty liver disease proxied by chronically elevated alanine transaminase levels and 34 extrahepatic diseases
Zhenqiu Liu, Chen Suo, Hong Fan, et al.
Metabolism (2022) Vol. 135, pp. 155270-155270
Closed Access | Times Cited: 26
Causal relationships between metabolic‐associated fatty liver disease and iron status: Two‐sample Mendelian randomization
He He, Shenling Liao, Yuping Zeng, et al.
Liver International (2022) Vol. 42, Iss. 12, pp. 2759-2768
Closed Access | Times Cited: 25
Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease: A 2-Sample Bidirectional Mendelian Randomization Study
Shiwei Li, Yuhong Fu, Yue Liu, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 8, pp. e3497-e3503
Open Access | Times Cited: 24
Association between the gut microbiota and nonalcoholic fatty liver disease: A two-sample Mendelian randomization study
Yu Li, Xifeng Liang, Yaning Lyu, et al.
Digestive and Liver Disease (2023) Vol. 55, Iss. 11, pp. 1464-1471
Open Access | Times Cited: 15
Causal association of NAFLD with osteoporosis, fracture and falling risk: a bidirectional Mendelian randomization study
Aiyong Cui, Peilun Xiao, Zhiqiang Fan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 14
Depression and hepatobiliary diseases: a bidirectional Mendelian randomization study
Yu Kong, Zhongcai Yao, Lingli Ren, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 6
Regional variation in NAFLD prevalence and risk factors among people living with HIV in Europe: a meta-analysis
Dachuan Jin, Shunqin Jin, Tao Zhou, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 5
Machine learning across multiple imaging and biomarker modalities in the UK Biobank improves genetic discovery for liver fat accumulation
Hari Somineni, Sumit Mukherjee, David Amar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top